Terms: = Ovarian cancer AND MYCN, N-myc, 4613, ENSG00000134323, NMYC, MODED, ODED AND Prognosis
9 results:
1. n-myc Downstream Regulated Gene-1 May Play an Important Role in the prognosis of ovarian cancer, in Its Association with Beta-Catenin.
Terada A; Tsuda N; Tasaki S; Park J; Nasu H; Tasaki K; Katsuda T; Nishio S; Yamaguchi T; Sanada S; Akiba J; Kuwano M; Ono M; Ushijima K
Kurume Med J; 2023 Nov; 69(1.2):39-46. PubMed ID: 37793886
[TBL] [Abstract] [Full Text] [Related]
2. Evaluation of circulating Dickkopf-1 as a prognostic biomarker in ovarian cancer patients.
Klotz DM; Link T; Goeckenjan M; Wimberger P; Poetsch AR; Jaschke N; Hofbauer LC; Göbel A; Rachner TD; Kuhlmann JD
Clin Chem Lab Med; 2022 Jan; 60(1):109-117. PubMed ID: 34687595
[TBL] [Abstract] [Full Text] [Related]
3. ABCC4/MRP4 contributes to the aggressiveness of Myc-associated epithelial ovarian cancer.
Jung M; Gao J; Cheung L; Bongers A; Somers K; Clifton M; Ramsay EE; Russell AJ; Valli E; Gifford AJ; George J; Kennedy CJ; Wakefield MJ; Topp M; Ho GY; ; Scott CL; Bowtell DD; deFazio A; Norris MD; Haber M; Henderson MJ
Int J Cancer; 2020 Oct; 147(8):2225-2238. PubMed ID: 32277480
[TBL] [Abstract] [Full Text] [Related]
4. Annual Report of the Committee on Gynecologic Oncology, Japan Society of Obstetrics and Gynecology: Patient Annual Report for 2014 and Treatment Annual Report for 2009.
Saito T; Takahashi F; Katabuchi H;
J Obstet Gynaecol Res; 2017 Nov; 43(11):1667-1677. PubMed ID: 28892220
[TBL] [Abstract] [Full Text] [Related]
5. A Myc Activity Signature Predicts Poor Clinical Outcomes in Myc-Associated cancers.
Jung M; Russell AJ; Liu B; George J; Liu PY; Liu T; DeFazio A; Bowtell DD; Oberthuer A; London WB; Fletcher JI; Haber M; Norris MD; Henderson MJ
Cancer Res; 2017 Feb; 77(4):971-981. PubMed ID: 27923830
[TBL] [Abstract] [Full Text] [Related]
6. Primary ovarian neuroblastoma.
Muhlstein J; Rodriguez-Dahlhoff S; Marie B; Fouyssac F
J Pediatr Adolesc Gynecol; 2010 Oct; 23(5):263-6. PubMed ID: 20371194
[TBL] [Abstract] [Full Text] [Related]
7. Expression and amplification of the HER-2/neu (c-erbB-2) protooncogene in epithelial ovarian tumors and cell lines.
Tyson FL; Boyer CM; Kaufman R; O'Briant K; Cram G; Crews JR; Soper JT; Daly L; Fowler WC; Haskill JS
Am J Obstet Gynecol; 1991 Sep; 165(3):640-6. PubMed ID: 1679963
[TBL] [Abstract] [Full Text] [Related]
8. [Oncogene and patient prognosis].
Ito H; Tahara E
Gan To Kagaku Ryoho; 1991 Jun; 18(7):1075-83. PubMed ID: 2053766
[TBL] [Abstract] [Full Text] [Related]
9. [A study of amplifications of myc gene (c-myc and n-myc) in human ovarian cancer].
Kataoka A; Yakushiji M; Kojiro M
Nihon Sanka Fujinka Gakkai Zasshi; 1990 Mar; 42(3):259-63. PubMed ID: 2332674
[TBL] [Abstract] [Full Text] [Related]